Glyoxalase I (Glo1) and its metabolites in vascular disease

Biochemical Society Transactions

Volumn 42, Issue 2, 2014, Pages 528-533

  Wortmann, Markus ^a   Peters, Andreas S ^a   Hakimi, Maani ^a   Böckler, Dittmar ^a   Dihlmann, Susanne ^a  

^a UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

Author keywords

Atherosclerosis; Cardiovascular disease; Diabetes; Glyoxalase I; Glyoxalase system; Vascular disease

Indexed keywords

ADVANCED GLYCATION END PRODUCT; LACTOYLGLUTATHIONE LYASE; METHYLGLYOXAL;

ATHEROSCLEROSIS; DIABETIC MICROANGIOPATHY; DIABETIC NEPHROPATHY; DIABETIC PATIENT; DIABETIC RETINOPATHY; ENDOTHELIAL DYSFUNCTION; HUMAN; HYPERTENSION; METABOLITE; PATHOPHYSIOLOGY; PRIORITY JOURNAL; REVIEW; VASCULAR DISEASE; ANIMAL; ENZYMOLOGY; METABOLISM;

ANIMALS; ATHEROSCLEROSIS; HUMANS; LACTOYLGLUTATHIONE LYASE; VASCULAR DISEASES;

EID: 84896948938     PISSN: 03005127     EISSN: 14708752     Source Type: Journal    
DOI: 10.1042/BST20140003     Document Type: Review

References (50)

1. Mitchell, R.N. and Schoen, F.J. (2009) Blood vessels. In Robbins and Cotran's Pathologic Basis of Disease (8th edn), pp. 487-528, Saunders Elsevier, Philadelphia
2. Kovacic, J.C., Moreno, P., Nabel, E.G., Hachinski, V. and Fuster, V. (2011) Cellular senescence, vascular disease, and aging. Part 2 of a 2-part review: clinical vascular disease in the elderly. Circulation 123, 1900-1910
3. Brownlee, M. (2001) Biochemistry and molecular cell biology of diabetic complications. Nature 414, 813-820
4. Xue, M., Rabbani, N. and Thornalley, P.J. (2011) Glyoxalase in ageing. Semin. Cell Dev. Biol. 22, 293-301
5. Rabbani, N. and Thornalley, P.J. (2012) Methylglyoxal, glyoxalase 1 and the dicarbonyl proteome. Amino Acids 42, 1133-1142
6. Bierhaus, A., Stern, D.M. and Nawroth, P.P. (2006) RAGE in inflammation: a new therapeutic target? Curr. Opin. Invest. Drugs 7, 985-991 (Pubitemid 44756124)
7. Kirk, J.E. (1960) The glyoxalase I activity of arterial tissue in individuals of various ages. J. Gerontol. 15, 139-141
8. Hanssen, N.M., Wouters, K., Huijberts, M.S., Gijbels, M.J., Sluimer, J.C., Scheijen, J.L., Heeneman, S., Biessen, E.A., Daemen, M.J., Brownlee, M. et al. (2013) Higher levels of advanced glycation endproducts in human carotid atherosclerotic plaques are associated with a rupture-prone phenotype. Eur. Heart J., doi:10.1093/eurheartj/eht402
9. Wautier, J.L. and Schmidt, A.M. (2004) Protein glycation: a firm link to endothelial cell dysfunction. Circ. Res. 95, 233-238
10. Deanfield, J.E., Halcox, J.P. and Rabelink, T.J. (2007) Endothelial function and dysfunction: testing and clinical relevance. Circulation 115, 1285-1295 (Pubitemid 46594773)
11. Brouwers, O., Niessen, P.M., Miyata, T., Ostergaard, J.A., Flyvbjerg, A., Peutz-Kootstra, C.J., Sieber, J., Mundel, P.H., Brownlee, M., Janssen, B.J. et al. (2014) Glyoxalase-1 overexpression reduces endothelial dysfunction and attenuates early renal impairment in a rat model of diabetes. Diabetologia 57, 224-235
12. Akhand, A.A., Hossain, K., Mitsui, H., Kato, M., Miyata, T., Inagi, R., Du, J., Takeda, K., Kawamoto, Y., Suzuki, H. et al. (2001) Glyoxal and methylglyoxal trigger distinct signals for MAP family kinases and caspase activation in human endothelial cells. Free Radic. Biol. Med. 31, 20-30 (Pubitemid 32568420)
13. Su, Y., Lei, X., Wu, L. and Liu, L. (2012) The role of endothelial cell adhesion molecules P-selectin, E-selectin and intercellular adhesion molecule-1 in leucocyte recruitment induced by exogenous methylglyoxal. Immunology 137, 65-79
14. Yamawaki, H., Saito, K., Okada, M. and Hara, Y. (2008) Methylglyoxal mediates vascular inflammation via JNK and p38 in human endothelial cells. Am. J. Physiol. Cell Physiol. 295, C1510-C1517
15. Gale, C.P., Futers, T.S. and Summers, L.K. (2004) Common polymorphisms in the glyoxalase-1 gene and their association with pro-thrombotic factors. Diab. Vasc. Dis. Res. 1, 34-39
16. Engelen, L., Ferreira, I., Brouwers, O., Henry, R.M., Dekker, J.M., Nijpels, G., Heine, R.J., van Greevenbroek, M.M., van der Kallen, C.J., Blaak, E.E. et al. (2009) Polymorphisms in glyoxalase 1 gene are not associated with vascular complications: the Hoorn and CoDAM studies. J. Hypertens. 27, 1399-1403
17. Degaffe, G.H., Vander Jagt, D.L., Bobelu, A., Bobelu, J., Neha, D., Waikaniwa, M., Zager, P. and Shah, V.O. (2008) Distribution of glyoxalase I polymorphism among Zuni Indians: the Zuni Kidney Project. J. Diabetes Complications 22, 267-272 (Pubitemid 351885490)
18. Wu, J.C., Li, X.H., Wang, J.B., Tang, J.F., Wang, Y.F. and Peng, Y.D. (2011) Glyoxalase I and aldose reductase gene polymorphisms and susceptibility to carotid atherosclerosis in type 2 diabetes. Genet. Test. Mol. Biomarkers 15, 273-279
19. Sakhi, A.K., Berg, J.P. and Berg, T.J. (2013) Glyoxalase 1 enzyme activity in erythrocytes and Ala111Glu polymorphism in type 1-diabetes patients. Scand. J. Clin. Lab. Invest. 73, 175-181
20. Henry, R.M., Kostense, P.J., Spijkerman, A.M., Dekker, J.M., Nijpels, G., Heine, R.J., Kamp, O., Westerhof, N., Bouter, L.M. and Stehouwer, C.D. (2003) Arterial stiffness increases with deteriorating glucose tolerance status: the Hoorn Study. Circulation 107, 2089-2095 (Pubitemid 36532189)
21. Gaens, K.H., van Der Kallen, C.J., van Greevenbroek, M.M., Feskens, E.J., Stehouwer, C.D. and Schalkwijk, C.G. (2008) Receptor for advanced glycation end product polymorphisms and type 2 diabetes: the CODAM study. Ann. N.Y. Acad. Sci. 1126, 162-165 (Pubitemid 351589275)
22. He, J. and Whelton, P.K. (1999) Elevated systolic blood pressure and risk of cardiovascular and renal disease: overview of evidence from observational epidemiologic studies and randomized controlled trials. Am. Heart J. 138, 211-219
23. Wang, X., Desai, K., Clausen, J.T. and Wu, L. (2004) Increased methylglyoxal and advanced glycation end products in kidney from spontaneously hypertensive rats. Kidney Int. 66, 2315-2321 (Pubitemid 41115295)
24. Wang, X., Desai, K., Chang, T. and Wu, L. (2005) Vascular methylglyoxal metabolism and the development of hypertension. J. Hypertens. 23, 1565-1573 (Pubitemid 41104829)
25. Reference deleted
26. Yao, D., Taguchi, T., Matsumura, T., Pestell, R., Edelstein, D., Giardino, I., Suske, G., Rabbani, N., Thornalley, P.J., Sarthy, V.P. et al. (2007) High glucose increases angiopoietin-2 transcription in microvascular endothelial cells through methylglyoxal modification of mSin3A. J. Biol. Chem. 282, 31038-31045 (Pubitemid 350035169)
27. Brouwers, O., Niessen, P.M., Haenen, G., Miyata, T., Brownlee, M., Stehouwer, C.D., De Mey, J.G. and Schalkwijk, C.G. (2010) Hyperglycaemia-induced impairment of endothelium-dependent vasorelaxation in rat mesenteric arteries is mediated by intracellular methylglyoxal levels in a pathway dependent on oxidative stress. Diabetologia 53, 989-1000
28. Mukohda, M., Okada, M., Hara, Y. and Yamawaki, H. (2012) Exploring mechanisms of diabetes-related macrovascular complications: role of methylglyoxal, a metabolite of glucose on regulation of vascular contractility. J. Pharmacol. Sci. 118, 303-310
29. Salim, S., Asghar, M., Taneja, M., Hovatta, I., Chugh, G., Vollert, C. and Vu, A. (2011) Potential contribution of oxidative stress and inflammation to anxiety and hypertension. Brain Res. 1404, 63-71
30. Kim, Y.W. and Byzova, T.V. (2014) Oxidative stress in angiogenesis and vascular disease. Blood 123, 625-631
31. Taniguchi, N., Takahashi, M., Sakiyama, H., Park, Y.S., Asahi, M., Misonou, Y. and Miyamoto, Y. (2005) A common pathway for intracellular reactive oxygen species production by glycoxidative and nitroxidative stress in vascular endothelial cells and smooth muscle cells. Ann. N.Y. Acad. Sci. 1043, 521-528 (Pubitemid 41123941)
32. Vasdev, S., Gill, V. and Singal, P. (2007) Role of advanced glycation end products in hypertension and atherosclerosis: therapeutic implications. Cell Biochem. Biophys. 49, 48-63 (Pubitemid 47415346)
33. Morcos, M., Du, X., Pfisterer, F., Hutter, H., Sayed, A.A., Thornalley, P., Ahmed, N., Baynes, J., Thorpe, S., Kukudov, G. et al. (2008) Glyoxalase-1 prevents mitochondrial protein modification and enhances lifespan in Caenorhabditis elegans. Aging Cell 7, 260-269 (Pubitemid 351359658)
34. Desai, K.M., Chang, T., Wang, H., Banigesh, A., Dhar, A., Liu, J., Untereiner, A. and Wu, L. (2010) Oxidative stress and aging: is methylglyoxal the hidden enemy? Can. J. Physiol. Pharmacol. 88, 273-284
35. Sena, C.M., Matafome, P., Crisostomo, J., Rodrigues, L., Fernandes, R., Pereira, P. and Seica, R.M. (2012) Methylglyoxal promotes oxidative stress and endothelial dysfunction. Pharmacol. Res. 65, 497-506
36. Kollros, P.R. and Konkle, B.A. (1997) Microvascular disease in diabetes mellitus. J. Cardiovasc. Risk 4, 70-75 (Pubitemid 27374957)
37. Arora, M.K. and Singh, U.K. (2013) Molecular mechanisms in the pathogenesis of diabetic nephropathy: an update. Vasc. Pharmacol. 58, 259-271
38. Quinn, M., Angelico, M.C., Warram, J.H. and Krolewski, A.S. (1996) Familial factors determine the development of diabetic nephropathy in patients with IDDM. Diabetologia 39, 940-945 (Pubitemid 26249113)
39. Seaquist, E.R., Goetz, F.C., Rich, S. and Barbosa, J. (1989) Familial clustering of diabetic kidney disease: evidence for genetic susceptibility to diabetic nephropathy. N. Engl. J. Med. 320, 1161-1165 (Pubitemid 19124296)
40. Giacco, F., Du, X., D'Agati, V.D., Milne, R., Sui, G., Geoffrion, M. and Brownlee, M. (2014) Knockdown of Glo1 mimics diabetic nephropathy in non-diabetic mice. Diabetes 63, 291-299
41. Kim, K.M., Kim, Y.S., Jung, D.H., Lee, J. and Kim, J.S. (2012) Increased glyoxalase I levels inhibit accumulation of oxidative stress and an advanced glycation end product in mouse mesangial cells cultured in high glucose. Exp. Cell Res. 318, 152-159
42. Liu, Y.W., Zhu, X., Zhang, L., Lu, Q., Wang, J.Y., Zhang, F., Guo, H., Yin, J.L. and Yin, X.X. (2013) Up-regulation of glyoxalase 1 by mangiferin prevents diabetic nephropathy progression in streptozotocin-induced diabetic rats. Eur. J. Pharmacol. 721, 355-364
43. Ola, M.S., Nawaz, M.I., Siddiquei, M.M., Al-Amro, S. and Abu El-Asrar, A.M. (2012) Recent advances in understanding the biochemical and molecular mechanism of diabetic retinopathy. J. Diabetes Complications 26, 56-64
44. Miller, A.G., Tan, G., Binger, K.J., Pickering, R.J., Thomas, M.C., Nagaraj, R.H., Cooper, M.E. and Wilkinson-Berka, J.L. (2010) Candesartan attenuates diabetic retinal vascular pathology by restoring glyoxalase-I function. Diabetes 59, 3208-3215
45. Miller, A.G., Smith, D.G., Bhat, M. and Nagaraj, R.H. (2006) Glyoxalase I is critical for human retinal capillary pericyte survival under hyperglycemic conditions. J. Biol. Chem. 281, 11864-11871 (Pubitemid 43855447)
46. Berner, A.K., Brouwers, O., Pringle, R., Klaassen, I., Colhoun, L., McVicar, C., Brockbank, S., Curry, J.W., Miyata, T., Brownlee, M. et al. (2012) Protection against methylglyoxal-derived AGEs by regulation of glyoxalase 1 prevents retinal neuroglial and vasodegenerative pathology. Diabetologia 55, 845-854
47. Wu, J.C., Li, X.H., Peng, Y.D., Wang, J.B., Tang, J.F. and Wang, Y.F. (2011) Association of two glyoxalase I gene polymorphisms with nephropathy and retinopathy in Type 2 diabetes. J. Endocrinol. Invest. 34, e343-e348
48. Kalousova, M., Germanova, A., Jachymova, M., Mestek, O., Tesar, V. and Zima, T. (2008) A419C (E111A) polymorphism of the glyoxalase I gene and vascular complications in chronic hemodialysis patients. Ann. N.Y. Acad. Sci. 1126, 268-271 (Pubitemid 351589274)
49. Groener, J.B., Reismann, P., Fleming, T., Kalscheuer, H., Lehnhoff, D., Hamann, A., Roser, P., Bierhaus, A., Nawroth, P.P. and Rudofsky, G. (2013) C332C genotype of glyoxalase 1 and its association with late diabetic complications. Exp. Clin. Endocrinol. Diabetes 121, 436-439
50. Peculis, R., Konrade, I., Skapare, E., Fridmanis, D., Nikitina-Zake, L., Lejnieks, A., Pirags, V., Dambrova, M. and Klovins, J. (2013) Identification of glyoxalase 1 polymorphisms associated with enzyme activity. Gene 515, 140-143